Kaye Edward M. MD's Form 4 filing
Stoke Therapeutics, Inc. (STOK) · filed Sep 3, 2025
- Accession no.
- 0001415889-25-023590
- Filed
- Sep 3, 2025
- Trade date
- Aug 29-Sep 3, 2025
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market sales total $1.25M. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Kaye Edward M. MDCIK 0001522780 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 29, 2025 | Common Stock | SSaleDisposed | −1,029 | $20.00 | −$20,580 | 152,441 | Direct | |
| Sep 2, 2025 | Common Stock | SSaleDisposed | −14,860 | $20.14 | −$299,280.4 | 137,581 | Direct | |
| Sep 3, 2025 | Common Stock | SSaleDisposed | −45,996 | $20.13 | −$925,899.48 | 91,585 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.